Table 1.
Demographic characteristics on study subjects.
| Groups | No. of subjects | Age (mean ± S.D.) | Gender∗ | Sampling site | Villous abnormalities (as per Modified Marsh criteria) | HLA Haplotype | tTG Titre (mean ± SD) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | F | S | B | 0 | 1 | 3a | 3b | 3c | DQ2 | DQ8 | DQ2+ DQ8+ | ||||
| CeD | 23 | 23.4 ± 9.5 | 10 | 13 | 21 | 16 | 0 | 0 | 2 | 7 | 14 | 22 | 1 | 0 | 199.9 ± 72.1 |
| FDR | 15 | 31.6 ± 10.8 | 6 | 9 | 15 | 13 | 15 | 0 | 0 | 0 | 0 | 13 | 0 | 2 | 4.36 ± 2.6 |
| DC | 24 | 30.6 ± 12.3 | 22 | 2 | 23 | 14 | 22 | 2 | 0 | 0 | 0 | 6 | 0 | 0 | 4.09 ± 2.8 |
M = male, F = female, tTG = Tissue transglutaminase, S = Stool samples, B = Biopsy sample. ∗For the DC group our samples are biased by the higher representation of males compared to females.